Medigene stellt erste präklinische Daten zu mKRAS G12V kombiniert mit dem PD1-41BB kostimulatorischen Switch-Protein vor
Die Medigene AG (Medigene oder das "Unternehmen", FWB: MDG1, Prime Standard), ein immunonkologisches Plattformunternehme…
Die Medigene AG (Medigene oder das "Unternehmen", FWB: MDG1, Prime Standard), ein immunonkologisches Plattformunternehme…
Europe's leading provider of AI software for pathology, Mindpeak (Hamburg), has announced groundbreaking work with leadi…
The field of medical innovation is constantly evolving, and new breakthroughs are being made regularly. It's always a go…
Preclinical data published in Frontiers in Immunology, a leading peer-reviewed journal Induction of pro-inflammatory…
Apogenix, a biopharmaceutical company developing next generation immunotherapeutics, announced today that its partner CA…
As part of this year's BioTech Bootcamp of BioM Biotech Cluster GmbH and the life science business incubator "SmiLe Incu…
Allero Therapeutics BV, a Dutch oromucosal immunotherapy company, today announced that the Company has received a EUR 2.…
Interim clinical update on ACTengine® IMA203 TCR-T monotherapy targeting PRAME demonstrated high confirmed objective res…
The drug development company ISR has signed an agreement with Gerresheimer for large-scale production of the IcoOne nasa…
Marktführende Proteomik-Forschungdienstleistungen von Biognosys ergänzen das Angebot an Multiomics-Lösungen von Neo…